Biotech Stock Surges 300% as Olema Pharma Secures $68.7M for Breast Cancer Drug Development | MarketWire

Olema Pharmaceuticals (+300%) lands $68.7M in funding for clinical trials targeting a 2027 breast cancer drug launch.